# Jing Wang

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jing-wang-2/

## Facts

| Field | Value |
| --- | --- |
| Citations | 35,980 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 87 |
| i10-index | 276 |
| Last Known Institution | The University of Texas MD Anderson Cancer Center |
| OpenAlex ID | https://openalex.org/A5100378537 |
| ORCID iD | 0000-0002-5398-0802 |
| Works | 1,213 |

## Researcher papers

Showing 12 of 22.

- [<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma](https://scholariq.org/papers/i-stk11-lkb1-i-mutations-and-pd-1-inhibitor-resistance-in-i-kras-i-mutant-lung/)
- [Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade](https://scholariq.org/papers/distinct-cellular-mechanisms-underlie-anti-ctla-4-and-anti-pd-1-checkpoint/)
- [Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4](https://scholariq.org/papers/hijacking-the-e3-ubiquitin-ligase-cereblon-to-efficiently-target-brd4/)
- [Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression](https://scholariq.org/papers/metastasis-is-regulated-via-microrna-200-zeb1-axis-control-of-tumour-cell-pd-l1/)
- [Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities](https://scholariq.org/papers/patterns-of-transcription-factor-programs-and-immune-pathway-activation-define/)
- [Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead](https://scholariq.org/papers/lessons-in-protac-design-from-selective-degradation-with-a-promiscuous-warhead/)
- [Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer](https://scholariq.org/papers/targeting-dna-damage-response-promotes-antitumor-immunity-through-sting-mediated/)
- [PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer](https://scholariq.org/papers/protac-induced-bet-protein-degradation-as-a-therapy-for-castration-resistant/)
- [The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study](https://scholariq.org/papers/the-advantages-of-targeted-protein-degradation-over-inhibition-an-rtk-case-study/)
- [STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment](https://scholariq.org/papers/stk11-lkb1-deficiency-promotes-neutrophil-recruitment-and-proinflammatory/)
- [Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy](https://scholariq.org/papers/increased-tumor-glycolysis-characterizes-immune-resistance-to-adoptive-t-cell/)
- [A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition](https://scholariq.org/papers/a-patient-derived-pan-cancer-emt-signature-identifies-global-molecular/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [RNA modifications and cancer](https://scholariq.org/topics/rna-modifications-and-cancer/)

## Researcher university

- [The University of Texas MD Anderson Cancer Center](https://scholariq.org/institutions/the-university-of-texas-md-anderson-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.